Search

Displaying results 9511 - 9520 of 10000 in total
  1. Drug

    Lingdolinurad

    go.drugbank.com/drugs/DB21659
    Experimental

    Lingdolinurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Lingdolinurad is a urate transporter inhibitor.

  2. Drug

    Setidegrasib

    go.drugbank.com/drugs/DB21670
    Investigational

    Setidegrasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Setidegrasib is a Ras protein inhibitor.

  3. Drug

    Relicpixant

    go.drugbank.com/drugs/DB21671
    Experimental

    Relicpixant is a small molecule drug. The usage of the INN stem '-pixant' in the name indicates that Relicpixant is a purinoreceptor (P2X) antagonist.

  4. Drug

    Muvadenant

    go.drugbank.com/drugs/DB21684
    Experimental

    Muvadenant is a small molecule drug. The usage of the INN stem '-adenant' in the name indicates that Muvadenant is a adenosin receptor antagonist.

  5. Drug

    Darbinurad

    go.drugbank.com/drugs/DB21695
    Experimental

    Darbinurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Darbinurad is a urate transporter inhibitor.

  6. Drug

    Remlifanserin

    go.drugbank.com/drugs/DB21707
    Experimental

    Remlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist.

  7. Drug

    Envudeucitinib

    go.drugbank.com/drugs/DB21716
    Investigational

    Envudeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor.

  8. Drug

    Zemprocitinib

    go.drugbank.com/drugs/DB21719
    Experimental

    Zemprocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor.

  9. Drug

    Pegsitacianine

    go.drugbank.com/drugs/DB19098
    Investigational

    Pegsitacianine is under investigation in clinical trial NCT05576974 (A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence … Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)).

  10. Drug

    Gam-COVID-Vac

    go.drugbank.com/drugs/DB15848
    Investigational

    The vaccine is offered in both a frozen (Gam-COVID-Vac) and freeze-dried formulation (lyophilizate; Gam-COVID-Vac Lyo). … June 2020, and were completed in early August 2020.